EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Recent Advances in mRNA-LNP Delivery Systems for Extrahepatic Organs: A Review

Ying Bai, Li Cui, Tianshu Liu, Zhen Wang, Haiyan Cao, Shukun He, Jiani Qiu, Yingxin Li, Yilan Zhou, Jiawei Shi, Jing Wang iD

Molecular Pharmaceutics · 04.08.2025 · 22 (8) · 4474-4493

DOI: 10.1021/acs.molpharmaceut.5c00385 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Pharmaceutics, online erschienen am 11.07.2025. Verfasst von Ying Bai und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China. Hauptthemen laut MEDLINE: RNA, Messenger, Nanoparticles, Lipids, Gene Transfer Techniques. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 197 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lipid nanoparticles (LNPs) as gene delivery vectors have revolutionized the therapeutic paradigm in mRNA therapy. The pH-dependent lipid components can prevent endosomal retention of mRNA and promote the cytoplasmic translation of therapeutic proteins. However, current technologies still face two core challenges: the nonspecific liver accumulation rate of 30-90% after systemic administration, which is an organ targeting issue, and the inefficient cytoplasmic delivery with only 1-4% of nucleic acids escaping from endosomes. These problems severely limit their application in the treatment of extrahepatic diseases. This review systematically elaborates on the molecular composition and structure-function relationship of LNPs and explores the causes of their extrahepatic delivery obstacles. At the same time, we propose innovative strategies to enhance organ selectivity and endosomal escape efficiency. Additionally, through existing preclinical studies, key bottlenecks such as immune response control and quality control in large-scale production for the clinical translation of current technologies are revealed, providing a multidisciplinary theoretical framework for the development of the next generation of intelligent LNPs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, MessengerNanoparticlesLipidsGene Transfer TechniquesHumansAnimalsGenetic TherapyDrug Delivery SystemsLiposomes

Stichwörter der Autor:innen

extrahepatic targetinglipid nanoparticlesmRNA delivery

Substanzen

RNA, MessengerLipidsLipid NanoparticlesLiposomes

Autor:innen und Institutionen

  • Department of Ultrasound Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
  • Clinical Research Center for Medical Imaging in Hubei Province, Wuhan 430022, China.
  • Hubei Province Key Laboratory of Molecular Imaging, Wuhan 430022, China.

ORCID-Profile: Jing Wang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Bai, Y., Cui, L., Liu, T., Wang, Z., Cao, H., He, S., Qiu, J., Li, Y., Zhou, Y., Shi, J., & Wang, J. (2025). Recent Advances in mRNA-LNP Delivery Systems for Extrahepatic Organs: A Review. Molecular Pharmaceutics, 22(8), 4474-4493. https://doi.org/10.1021/acs.molpharmaceut.5c00385

Vancouver

Bai Y, Cui L, Liu T, Wang Z, Cao H, He S, et al. Recent Advances in mRNA-LNP Delivery Systems for Extrahepatic Organs: A Review. Molecular Pharmaceutics. 2025;22(8):4474-4493. doi:10.1021/acs.molpharmaceut.5c00385

BibTeX
@article{Bai2025,
  author = {Bai, Ying and Cui, Li and Liu, Tianshu and Wang, Zhen and Cao, Haiyan and He, Shukun and Qiu, Jiani and Li, Yingxin and Zhou, Yilan and Shi, Jiawei and Wang, Jing},
  title = {Recent Advances in mRNA-LNP Delivery Systems for Extrahepatic Organs: A Review},
  journal = {Molecular Pharmaceutics},
  year = {2025},
  volume = {22},
  number = {8},
  pages = {4474--4493},
  doi = {10.1021/acs.molpharmaceut.5c00385}
}
Kostenlos starten →